In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 ...

Products are not allowed to claim that they can have the same effects as prescription medicines, such as weight-loss jabs ...

AS trials suggest they can treat ever more illnesses and more people use them to slim down, it is clear weight loss jabs are ...

Glucagon-like peptide-1 (GLP-1) medications, such as Wegovy (semaglutide), have helped many people lose weight. Until recently, these options required regular injections — a potential dealbreaker for ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore told FOX Business on Friday. Wegovy’s once-daily pill, an oral spinoff of its ...

In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster injections ...

WASHINGTON — Novo Nordisk's weight-loss pill is now offered through Amazon's digital pharmacy. The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering ...